The result was 1982’s Nebraska, an acoustic gem released with no tour, press, or lead single. Bruce didn’t even want his face on the cover. Still, it reached number three on the Billboard chart, and is remembered by many as one of…
The governor of the Bank of England, Andrew Bailey, has warned recent events in US private credit markets have worrying echoes of the sub-prime mortgage crisis that kicked off the global financial crash of 2008.
Appearing before a House of Lords committee, the governor said it was important to have the “drains up” and analyse the collapse of two leveraged US firms, First Brands and Tricolor, in case they are not isolated events but “the canary in the coalmine”.
“Are they telling us something more fundamental about the private finance, private asset, private credit, private equity sector, or are they telling us that in any of these worlds there will be idiosyncratic cases that go wrong?” he asked.
The Bank of England governor, Andrew Bailey. Photograph: Alastair Grant/Reuters
“I think that is still a very open question; it’s an open question in the US.”
He added: “I don’t want to sound too foreboding, but the added reason this question is important is if you go back to before the financial crisis when we were having this debate about sub-prime mortgages in the US, people were telling us, ‘No it’s too small to be systemic, it’s idiosyncratic’… That was the wrong call.”
Bailey said the complex nature of some of the financial engineering in use in the private credit markets gave cause for concern.
“We certainly are beginning to see, for instance what used to be called slicing and dicing and tranching of loan structures going on, and if you were involved before the financial crisis and during it, alarm bells start going off at that point,” he told peers.
“That stuff was a feature of the financial crisis, so that’s another reason why we’ve got to use these cases as another reason to have more drains up, frankly.”
Deputy Bank governor Sarah Breeden, appearing alongside Bailey, said the Bank would be carrying out a war game exercise in these markets, to test the linkages between private credit and other sectors.
She underlined some of the concerns about the private credit sector. “It’s about high leverage, it’s about opacity, it’s about complexity and it’s about weak underwriting standards.
skip past newsletter promotion
after newsletter promotion
“Those are things that we were talking about in the abstract as a source of vulnerability in this bit of the financial system, and those appear to have been at play in the context of these two defaults.”
The collapse of car parts firm First Brands and auto lender Tricolor prompted concern on Wall Street, with the JP Morgan chief executive, Jamie Dimon, comparing them to “cockroaches”, and saying that more could emerge.
The International Monetary Fund’s global financial stability review last week highlighted concerns about the close connections between private credit markets and mainstream banks – and the IMF’s managing director, Kristalina Georgieva, said it was the issue that kept her awake at night.
We conducted an observational cohort study derived from an ongoing, prospective, multicenter surveillance network REA-REZO of ICU-acquired infections and associated risk factors. This cohort included individual patient data from 206…
The average age of PGDM mothers participating in the study was 31.72 ± 5.17, with 77% having a high school education or higher, 57.5% unemployed, 22.5% smoking, 25% having a chronic illness, and experiencing the most common complications…
A research team from the University of Zurich and the University Children’s Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system. By combining an approved drug with a…
Dobson R, Giovannoni G. Multiple sclerosis – a review. Eur J Neurol. 2019;26(1):27–40. https://doi.org/10.1111/ene.13819.
Article
PubMed
Google Scholar
Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and glialcam. Nature. 2022;603(7900):321–7. https://doi.org/10.1038/s41586-022-04432-7.
Article
PubMed
PubMed Central
Google Scholar
Bjornevik K, Münz C, Cohen JI, Ascherio A. Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. 2023;19(3):160–71. https://doi.org/10.1038/s41582-023-00775-5.
Article
PubMed
Google Scholar
Morandi E, Tanasescu R, Tarlinton RE, Constantinescu CS, Zhang W, Tench C, et al. The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis. PLoS ONE. 2017;12(2):e0172415. https://doi.org/10.1371/journal.pone.
Article
PubMed
PubMed Central
Google Scholar
Küry P, Nath A, Créange A, Dolei A, Marche P, Gold J, et al. Human endogenous retroviruses in neurological diseases. Trends Mol Med. 2018;24(4):379–94. https://doi.org/10.1016/j.molmed.2018.02.007.
Article
PubMed
PubMed Central
Google Scholar
Nevalainen T, Autio-Kimura A, Hurme M. Human endogenous retrovirus W in multiple sclerosis: transcriptional activity is associated with decline in oligodendrocyte proportions in the white matter of the brain. J Neurovirol. 2024;30(4):393–405. https://doi.org/10.1007/s13365-024-01208-9.
Article
PubMed
PubMed Central
Google Scholar
Gruchot J, Reiche L, Werner L, Herrero F, Schira-Heinen J, Meyer U, et al. Molecular dissection of HERV-W dependent microglial- and astroglial cell polarization. Microbes Infect. 2025;27(5–6):105382. https://doi.org/10.1016/j.micinf.2024.
Article
PubMed
Google Scholar
Kremer D, Gruchot J, Weyers V, Oldemeier L, Gottle P, Healy L, et al. PHerv-w envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis. Proc Natl Acad Sci U S A. 2019;116(30):15216–25. https://doi.org/10.1073/pnas.1901283116.
Article
PubMed
PubMed Central
Google Scholar
Gruchot J, Lewen I, Dietrich M, Reiche L, Sindi M, Hecker C, et al. Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment. Proc Natl Acad Sci U S A. 2023;120(38):e2308187120. https://doi.org/10.1073/pnas.
Article
PubMed
PubMed Central
Google Scholar
Charvet B, Pierquin J, Brunel J, Gorter R, Quetard C, Horvat B, et al. Human endogenous retrovirus type W envelope from multiple sclerosis demyelinating lesions shows unique solubility and antigenic characteristics. Virol Sin. 2021;36(5):1006–26. 10.7/s12250-021-00372-0.
Article
PubMed
PubMed Central
Google Scholar
Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler. 2012;18(12):1721–36. 10.177/1352458512441381.
Article
PubMed
PubMed Central
Google Scholar
Ruberto S, Domınguez-Mozo MI, Garcıa-Martınez MA, Cossu D, Sechi LA, Alvarez-Lafuente R. Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression. Front Immunol. 2025;15:1505239. https://doi.org/10.3389/fimmu.2024.
Article
PubMed Central
Google Scholar
Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, et al. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS ONE. 2012;7(9):e44991. https://doi.org/10.1371/journal.pone.0044991.
Article
PubMed
PubMed Central
Google Scholar
Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, et al. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? PLoS ONE. 2013;8(11):e78474. https://doi.org/10.1371/journal.pone.0078474.
Article
PubMed
PubMed Central
Google Scholar
Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, et al. Exosomal microrna signatures in multiple sclerosis reflect disease status. Sci Rep. 2017;7(1):14293. https://doi.org/10.1038/s41598-017-14301-3.
Article
PubMed
PubMed Central
Google Scholar
Palazzo C, Asci I, Russo S, Buccoliero C, Mangialardi V, Abbrescia P, et al. Circulating exosomes with unique lipid signature in relapsing remitting multiple sclerosis. Front Cell Neurosci. 2025;19:1613618. https://doi.org/10.3389/fncel.2025.
Article
PubMed
PubMed Central
Google Scholar
D’Anca M, Fenoglio C, Buccellato FR, Visconte C, Galimberti D, Scarpini E. Extracellular vesicles in multiple sclerosis: role in the pathogenesis and potential usefulness as biomarkers and therapeutic tools. Cells. 2021;10(7):1733. https://doi.org/10.3390/cells10071733.
Article
PubMed
PubMed Central
Google Scholar
Teow SY, Liew K, Khoo AS, Peh SC. Pathogenic role of exosomes in Epstein-Barr virus (EBV)-associated cancers. Int J Biol Sci. 2017;13(10):1276–86. https://doi.org/10.7150/ijbs.19531.
Article
PubMed
PubMed Central
Google Scholar
Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis. Front Immunol. 2021;12:757302. https://doi.org/10.3389/fimmu.2021.
Article
PubMed
PubMed Central
Google Scholar
Mrad MF, Saba ES, Nakib L, Khoury SJ. Exosomes from subjects with multiple sclerosis express EBV-derived proteins and activate monocyte-derived macrophages. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1004. 10.212/NXI.0000000000001004.
Article
PubMed
PubMed Central
Google Scholar
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. https://doi.org/10.1016/S474-4422(17)30470-2.
Article
PubMed
Google Scholar
Kremer D, Forster M, Schichel T, Gottle P, Hartung HP, Perron H, et al. The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation Blockade. Mult Scler. 2015;21(9):1200–3. 10.177/1352458514560926.
Article
PubMed
Google Scholar
Hartung HP, Derfuss T, Cree BA, Sormani MP, Selmaj K, Stutters J, et al. Efficacy and safety of Temelimab in multiple sclerosis: results of a randomized phase 2b and extension study. Mult Scler. 2022;28(3):429–40. https://doi.org/10.1177/13524585211024997.
Article
PubMed
Google Scholar
Curtin F, Champion B, Davoren P, Duke S, Ekinci EI, Gilfillan C, et al. A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes. Diabetes Obes Metab. 2020;22(7):1111–21. 10./dom.14010.
Article
PubMed
Google Scholar
Simula ER, Jasemi S, Cossu D, Fais M, Cossu I, Chessa V, et al. Human endogenous retroviruses as novel therapeutic targets in neurodegenerative disorders. Vaccines. 2025;13(4):415. https://doi.org/10.3390/vaccines13040415.
Article
PubMed
PubMed Central
Google Scholar
Chen J, Foroozesh M, Qin Z. Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies. Oncogenesis. 2019;8(1):6. https://doi.org/10.1038/s41389-018-0114-y.
Article
PubMed
PubMed Central
Google Scholar
Brütting C, Stangl G, Staege M, Vitamin D. Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis – facts and hypotheses. J Integr Neurosci. 2021;20(1):233–8. https://doi.org/10.31083/j.jin.2021.01.392.
Article
PubMed
Google Scholar
Latifi T, Zebardast A, Marashi SM. The role of human endogenous retroviruses (HERVs) in multiple sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D. Mult Scler Relat Disord. 2022;57:103318. https://doi.org/10.1016/j.msard.2021.
Article
PubMed
Google Scholar
Gottle P, Schichel K, Reiche L, Werner L, Zink A, Prigione A, et al. TLR4 associated signaling disrupters as a new means to overcome HERV-W envelope-mediated myelination deficits. Front Cell Neurosci. 2021;15:777542. https://doi.org/10.3389/fncel.2021.
Article
PubMed
PubMed Central
Google Scholar
Osaid Z, Haider M, Hamoudi R, Harati R. Exosomes interactions with the blood–brain barrier: implications for cerebral disorders and therapeutics. Int J Mol Sci. 2023;24(21):15635. https://doi.org/10.3390/ijms242115635.
Article
PubMed
PubMed Central
Google Scholar
Gimenez-Orenga K, Oltra E. Human endogenous retrovirus as therapeutic targets in neurologic disease. Pharmaceuticals (Basel). 2021;14(6):495. https://doi.org/10.3390/ph14060495.
Article
PubMed
Google Scholar
Adler GL, Le K, Fu Y, Kim WS. Human endogenous retroviruses in neurodegenerative diseases. Genes. 2024;15(6):745. https://doi.org/10.3390/genes15060745.
Article
PubMed
PubMed Central
Google Scholar
Bhetariya PJ, Kriesel JD, Fischer KF. Analysis of human endogenous retrovirus expression in multiple sclerosis plaques. J Emerg Dis Virol. 2017;3(2). https://doi.org/10.16966/2473-1846.133.
Moyes DL, Goris A, Ban M, Compston A, Griffiths DJ, Sawcer S, et al. HERV-K113 is not associated with multiple sclerosis in a large family-based study. AIDS Res Hum Retroviruses. 2008;24(3):363–5. https://doi.org/10.1089/aid.2007.0196.
Article
PubMed
Google Scholar
Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, Møller-Larsen A. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology. 2009;6:104. https://doi.org/10.1186/742-4690-6-104.
Article
PubMed
PubMed Central
Google Scholar
Laska MJ, Brudek T, Nissen KK, Christensen T, Moller-Larsen A, Petersen T, et al. Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol. 2012;86(7):3713–22. https://doi.org/10.1128/JVI.06723-11.
Article
PubMed
PubMed Central
Google Scholar
Censi ST, Mariani-Costantini R, Granzotto A, Tomassini V, Sensi SL. Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model. Ageing Res Rev. 2024;99:102392. https://doi.org/10.1016/j.arr.2024.
Article
PubMed
Google Scholar
Ruberto S, Cossu D, Sechi LA. Correlation between antibodies against the pathogenic pHERV-W envelope protein and the inflammatory phase of multiple sclerosis. Immunology. 2024;171(2):270–6. https://doi.org/10.1111/imm.13712.
Article
PubMed
Google Scholar
Lyu L, Li Q, Wang C. EBV latency programs: molecular and epigenetic regulation and its role in disease pathogenesis. J Med Virol. 2025;97(7):e70501. https://doi.org/10.1002/jmv.
Article
PubMed
PubMed Central
Google Scholar
Aarts SABM, Seijkens TTP, Dorst KJFv, Dijkstra CD, Kooij G, Lutgens E. The CD40–CD40L dyad in experimental autoimmune encephalomyelitis and multiple sclerosis. Front Immunol. 2017;8:1791. https://doi.org/10.3389/fimmu.2017.01791.
Article
PubMed
PubMed Central
Google Scholar
Vermersch P, Wagner D, Mars LT, Noelle R, Giovannoni G. Inhibiting CD40 ligand in multiple sclerosis: a review of emerging therapeutic potential. Curr Treat Options Neurol. 2025;27:7. https://doi.org/10.1007/s11940-024-00818-2.
Article
Google Scholar
Orian JM, D’Souza CS, Kocovski P, Krippner G, Hale MW, Wang X, et al. Platelets in multiple sclerosis: early and central mediators of inflammation and neurodegeneration and attractive targets for molecular imaging and site-directed therapy. Front Immunol. 2021;12:620963. https://doi.org/10.3389/fimmu.2021.
Article
PubMed
PubMed Central
Google Scholar
Burnouf T, Walker TL. The multifaceted role of platelets in mediating brain function. Blood. 2022;140(8):815–27. https://doi.org/10.1182/blood.2022015970.
Article
PubMed
PubMed Central
Google Scholar
Brudek T, Christensen T, Petersen T, Møller-Larsen A. Expression of HERV-H/W Env epitopes on PBMCs from MS patients with active disease. Retrovirology. 2011;8(Suppl 1):A210. https://doi.org/10.1186/742-4690-8-S1-A210.
Article
PubMed Central
Google Scholar
Chunder R, Schropp V, Kuerten S. B cells in multiple sclerosis and virus-induced neuroinflammation. Front Neurol. 2020;11:591894. https://doi.org/10.3389/fneur.2020.
Article
PubMed
PubMed Central
Google Scholar
Garcia-Montojo M, Rodríguez-Martín E, Ramos-Mozo P, Ortega-Madueño I, Domínguez-Mozo M, Arias-Leal A, et al. Syncytin‐1/HERV‐W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients. Eur J Immunol. 2020;50(5):685–94. https://doi.org/10.1002/eji.201948423.
Article
PubMed
Google Scholar
Banks WA, Sharma P, Bullock KM, Hansen KM, Ludwig N, Whiteside TL. Transport of extracellular vesicles across the Blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci. 2020;21(12):4407. https://doi.org/10.3390/ijms21124407.
Article
PubMed
PubMed Central
Google Scholar
Gjelstrup MC, Stilund M, Petersen T, Møller H, Petersen EL, Christensen T. Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis. Immunol Cell Biol. 2017;96(2):160–74. https://doi.org/10.1111/imcb.025.
Article
PubMed
PubMed Central
Google Scholar
Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S. The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci. 2021;15:642384. https://doi.org/10.3389/fnins.2021.
Article
PubMed
PubMed Central
Google Scholar
Virata MCA, Catahay JA, Lippi G, Henry BM. Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapies. Neurodegener Dis Manag. 2024;14(6):227–39. https://doi.org/10.1080/17582024.2024.2421738.
Article
Google Scholar
Steffen F, Uphaus T, Ripfel N, Fleischer V, Schraad M, Gonzalez-Escamilla G, et al. Serum neurofilament identifies patients with multiple sclerosis with severe focal axonal damage in a 6-year longitudinal cohort. Neurol Neuroimmunol Neuroinflamm. 2023;10(1):e200055. https://doi.org/10.1212/NXI.0000000000200055.
Article
PubMed
Google Scholar
Freedman MS, Abdelhak A, Bhutani MK, Freeman J, Gnanapavan S, Hussain S, et al. The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review. J Neurol. 2025;272(6):400. https://doi.org/10.1007/s00415-025-13093-1.
This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
